-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Met Office Issues Yellow Snow Warning for Nottinghamshire on Tuesday
-
UK Defence Secretary Warns Russia Nukes Not for Negotiation as HMS Vengeance Returns
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
Sekur Private Data Ltd. Provides Update on Expected Closing of Non-Brokered Private Placement
-
iFabric Corp Announces Record Revenues for Q3 2026 and the Nine Months Ended September 30, 2026
-
RenX Enterprises Reports Record Third Quarter Revenue of $4.49 Million, Up 27.6% Year Over Year
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Poll Shows Two-Thirds of New York Voters Support Lifting Charter School Cap
-
Park Jin-young Denies Cult Allegations Against Firstfruits Group
-
Downing Street Defends PM's Speechwriting After AI Photo Emerges
Jared Leto on joining Marvel and turning into a vampire
Jared Leto has been a star for decades, but it's only now at 50 that he is fronting his first major blockbuster -- transforming into a vampire for new Marvel flick "Morbius".
Leto made his name in more independent and cult projects, such as his Oscar-winning turn in AIDS drama "Dallas Buyer's Club" or as a junkie in "Requiem for a Dream".
But he has no qualms about joining the superhero juggernaut with "Morbius", that is hitting cinemas around the world next week.
"You want Marvel to help pay the bills, then you can sneak in some other movies here and there," he told AFP during a visit to Paris.
"I'm excited. I've done a lot of smaller roles in bigger movies and made a career out of that, so it's interesting to star in a movie thats something new and different -- I like a big, fun popcorn movie."
Leto is not a total stranger to superhero flicks, of course, having taken a turn as the Joker in "Suicide Squad".
But now he is creating a character not yet seen in the Marvel Cinematic Universe: Dr Michael Morbius is a scientist suffering from an incurable disease who accidentally turns himself into a vampire while trying to find a cure, and then can't stop killing people for their blood.
"He's not exactly a hero, not a villain. He's somewhere in between -- there's a classic Jekyll and Hyde thing happening here," said Leto.
"I liked that there were three characters built into one. There was a significant transformation between them."
- 'I never watch them' -
For once, Leto was spared the extensive make-up, unlike his almost unrecognisable turn in last year's "The House of Gucci", or the fake nose and teeth he used for his creepy serial killer in "The Little Things".
"Originally they wanted to use prosthetics with the monster and I pushed them to embrace technology and CGI. I'm glad we did because it gave us a lot more freedom," he said, referring to computer generated imagery.
"I worked with people that have rare diseases. There was a certain way of walking that's actually common with stroke survivors. I didn't want to just get a cane and have a little limp or something -- I wanted to make it specific."
Leto first became a star in the 1990s as the heart-throb in teen drama "My So-Called Life" and has popped up in lots of cult favourites, including "Fight Club", "American Psycho" and "Blade Runner 2049".
Not that he has seen any of these -- Leto hasn't watched himself on screen since the premiere of "Requiem for a Dream" at Cannes in 2000.
"I never watch them. The whole goal as an actor is to be unselfconscious. So I do everything I can not to be thinking about myself from the outside," he said.
"That way, I never repeat myself. Maybe that's why my characters are so different."
P.Silva--AMWN